| 1. |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL].https://goldcopd.org/2017 GOLD Reports.
|
| 2. |
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease[EB/OL].https://goldcopd.org/2023-gold-report-2/.
|
| 3. |
Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med, 2010, 363(12): 1128-1138.
|
| 4. |
Han MK, Quibrera PM, Carretta EE, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med, 2017, 5(8): 619-626.
|
| 5. |
Calverley PMA, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med, 2007, 356(8): 775-789.
|
| 6. |
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med, 2008, 359(15): 1543-1554.
|
| 7. |
Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med, 2013, 1(1): 43-50.
|
| 8. |
Soler-Catalu?a JJ, Martínez-García Má, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax, 2005, 60: 925-931.
|
| 9. |
Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J, 2003, 21: 46s-53s.
|
| 10. |
Liang C, Mao XH, Niu HT, et al. Characteristics, management and in-hospital clinical outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in China: results from the phase I data of ACURE study. Int J Chron Obstruct Pulmon Dis, 2021, 16: 451-465.
|
| 11. |
Tabak YP, Sun XW, Johannes RS, et al. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med, 2009, 169(17): 1595-1602.
|
| 12. |
Johannesdottir SA, Christiansen CF, Johansen MB, et al. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ, 2013, 16(7): 897-906.
|
| 13. |
Vogelmeier CF, Diesing J, Kossack N, et al. COPD exacerbation history and impact on future exacerbations – 8-year retrospective observational database cohort study from Germany. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2407-2417.
|
1/5
WeChat